Newsfile Corp
02 Jul 2026, 13:37 UTC · 1h ago
GRAIL, Inc. (GRAL) Securities Fraud: Contact Berger Montague to Discuss Your Rights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Newsfile Corp
02 Jul 2026, 13:37 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
GRAIL's NHS-Galleri Trial failed to achieve a statistically significant reduction in Stage III-IV cancers. — The failure of a flagship product's primary clinical endpoint directly undermines the company's core value proposition and growth thesis.
-0.90Berger Montague PC has filed a class action lawsuit against GRAIL alleging securities fraud regarding the disclosure of trial results. — Legal actions for fraud create additional financial liabilities and reputational risk, though they usually follow the primary negative news event.
-0.40GRAIL shares experienced a single-day collapse of approximately 50.55% following the disclosure of the trial results on February 19, 2026. — While this describes a past event, it establishes the high volatility and severe market devaluation associated with the trial's failure.
-0.20Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a class action lawsuit following a 50% stock collapse and failure of its flagship trial to meet endpoints.
The company is being investigated following a class action filing.
The company is the subject of a securities fraud lawsuit notice.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
1h ago
